SLNCF fundamentals
An in-depth look to Silence Therapeutics, Plc. operating, investing, and financing activities
SLNCF free cash flow for Q1 24 is -8.95 M USD. For 2023, SLNCF free cash flow was -48.93 M USD and operating cash flow was -48.87 M USD.
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
TTM